ספיגת תרופות: גורמים המשפיעים על ספיגה במערכת העיכול

The small intestine provides superior drug absorption due to its larger surface area created by intestinal villi, combined with higher blood flow. In contrast, the stomach has a smaller surface area and a thick mucous layer that hinders diffusion. These anatomical and physiological features make the intestine the primary site for drug absorption.

Food interferes with drug absorption through two mechanisms: drugs form complexes with food constituents, reducing their bioavailability, and food delays gastric emptying, slowing the movement of drugs into the small intestine. This delayed transit further reduces the rate of intestinal absorption, ultimately decreasing overall drug absorption.

P-glycoprotein transporters in the gut epithelium actively pump drugs back into the gut lumen, reducing their absorption into the bloodstream. This efflux mechanism acts as a barrier to drug absorption, limiting the amount of drug that enters systemic circulation from the gastrointestinal tract.

Weakly acidic drugs are predominantly nonionized in the stomach's acidic environment, allowing them to cross the stomach lining more easily through passive diffusion. In contrast, drugs in the upper intestine are often ionized, making them less able to penetrate the intestinal epithelium, resulting in lower absorption rates.

Diarrhea accelerates the movement of gut contents through the gastrointestinal tract, reducing the time available for drug absorption. This rapid transit limits drug contact with the intestinal epithelium, resulting in decreased absorption and lower drug bioavailability in the bloodstream overall.

Surface area directly influences absorption rates: the intestine's larger surface area, enhanced by villi, supports greater drug absorption compared to the stomach's smaller surface. Combined with higher intestinal blood flow, this increased surface area facilitates more efficient drug uptake into systemic circulation.

Drug ionization state determines absorption efficiency at specific GI locations. Nonionized drugs, like weakly acidic drugs in the acidic stomach, cross membranes readily. Ionized drugs in the upper intestine have reduced membrane permeability, though the intestine's superior surface area and blood flow often compensate for lower ionization-based absorption.